Filing Flows › Cardio Diagnostics Holdings (CDIO) › Q4 2025
Cardio Diagnostics Holdings (CDIO) Q4 2025 earnings results (fourth quarter 2025)
10-K filed Mar 13, 2026
Cardio Diagnostics Holdings (CDIO) reported revenue of $4K for the fourth quarter 2025 (Q4 2025), -21% from a year earlier and +25% from the quarter before.
Cardio Diagnostics Holdings, Q4 2025: revenue $4K (-21% year over year), net loss $1.5M, operating cash flow −$1.4M. The chart follows the revenue to costs, profit and cash.
| Q4 2025 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $4K | +25% | -21% |
| Operating profit | −$1.5M | — | — |
| Net earnings | −$1.5M | — | — |
| Operating cash flow | −$1.4M | — | — |
What changed
Revenue was $4K in Q4 2025, down 21% year over year and up 25% from the previous quarter.
Operating costs exceeded revenue by $1.5M, an operating margin of -41159.5%. Total costs fell 4% while revenue fell 21%. The fastest-growing cost line was Other operating costs (+21959%). The quarter ended with a net loss of $1.5M, narrower than the previous quarter's $1.7M loss.
Operating cash flow was −$1.4M. Non-cash charges added back $44K of depreciation and amortization and $24K of share-based compensation.
Questions
What was Cardio Diagnostics Holdings' revenue in the fourth quarter 2025?
Cardio Diagnostics Holdings (CDIO) reported revenue of $4K for the fourth quarter 2025 (Q4 2025), -21% from a year earlier and +25% from the quarter before.